|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-34.12/--
|
企业价值
32.89M
|
资产负债 |
每股账面净值
37.93
|
现金流量 |
现金流量率
--
|
损益表 |
收益
412.00K
|
每股收益
0.56
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/14 11:27 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19. |